Axogen AXGN
NASDAQ AXGN
$42.21 -0.23 (-0.54%)
As of: Sep 30, 2026 · 10:11 AM EDT

Axogen (AXGN) EV to EBITDA (2024 - 2025)

Updated

Axogen's (AXGN) EV to EBITDA was 72.27 for Q3 2025, up 34.0% from the prior quarter.

Analysis

Axogen (AXGN) EV to EBITDA (2024 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Axogen's EV to EBITDA came in at 64.42; for FY2024, it was 201.36.

  • Five-year quarterly EV to EBITDA spans a low of 53.95 in Q2 2025 and a high of 201.30 in Q4 2024.
  • Per Business Quant data, the three quarters before Q3 2025 came in at 53.95 (Q2 2025), 124.99 (Q1 2025) and 201.30 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Axogen 2.33 Bn 2.04 Bn 50.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 72.27
Jun 30, 2025 53.95
Mar 31, 2025 124.99
Dec 31, 2024 201.30
API Access

Axogen EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AXGN&period=max&api_key=YOUR_API_KEY